Trials / Not Yet Recruiting
Not Yet RecruitingNCT07231900
Sodium Bicarbonate in Intra-dialytic Hypertension in Chronic Hemodialysis Patients
- Status
- Not Yet Recruiting
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Assaf-Harofeh Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to diminish intra-dialytic hypertension in chrnic hemodialysis patients suffering from metabolic acidosis (low bicarbonate levels). The intervention is a tab of 500 mg sodium bicarbonate twice a day for one month, vs. placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Bicarbonate (NaHCO3) | Prescribing Sodium Bicaronate for intra-dualytic hypertension |
| DRUG | Placebo | 1 tab X 2/day |
Timeline
- Start date
- 2025-11-10
- Primary completion
- 2027-12-01
- Completion
- 2027-12-01
- First posted
- 2025-11-17
- Last updated
- 2025-11-17
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT07231900. Inclusion in this directory is not an endorsement.